Literature DB >> 23653370

The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.

Morten Andersen, Ulf Bergman, Nam-Kyong Choi, Tobias Gerhard, Cecilia Huang, Jessica Jalbert, Michio Kimura, Tomomi Kimura, Kiyoshi Kubota, Edward Chia-Cheng Lai, Nobuhiro Ooba, Byung-Joo Park, Nicole Pratt, Elizabeth E Roughead, Tsugumichi Sato, Soko Setoguchi, Ju-Young Shin, Anders Sundström, Yea-Huei Kao Yang.   

Abstract

Mesh:

Year:  2013        PMID: 23653370     DOI: 10.1002/pds.3439

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  23 in total

1.  Common Models, Different Approaches.

Authors:  Joshua J Gagne
Journal:  Drug Saf       Date:  2015-08       Impact factor: 5.606

2.  Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.

Authors:  Shirley V Wang; Olga V Patterson; Joshua J Gagne; Jeffrey S Brown; Robert Ball; Pall Jonsson; Adam Wright; Li Zhou; Wim Goettsch; Andrew Bate
Journal:  Drug Saf       Date:  2019-11       Impact factor: 5.606

Review 3.  Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.

Authors:  Edward Chia-Cheng Lai; Nicole Pratt; Cheng-Yang Hsieh; Swu-Jane Lin; Anton Pottegård; Elizabeth E Roughead; Yea-Huei Kao Yang; Jesper Hallas
Journal:  Eur J Epidemiol       Date:  2017-07-11       Impact factor: 8.082

4.  An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.

Authors:  Mickael Arnaud; Bernard Bégaud; Frantz Thiessard; Quentin Jarrion; Julien Bezin; Antoine Pariente; Francesco Salvo
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

5.  The hope, hype and reality of Big Data for pharmacovigilance.

Authors:  Andrew Bate; Robert F Reynolds; Patrick Caubel
Journal:  Ther Adv Drug Saf       Date:  2017-10-31

6.  The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers.

Authors:  Nicole Pratt; Ximena Camacho; Claire Vajdic; Louisa Degenhardt; Tracey-Lea Laba; Jodie Hillen; Christopher Etherton-Beer; David Preen; Louisa Jorm; Natasha Donnolley; Alys Havard; Sallie-Anne Pearson
Journal:  Int J Popul Data Sci       Date:  2022-06-13

Review 7.  A comparison of active adverse event surveillance systems worldwide.

Authors:  Yu-Lin Huang; Jinhee Moon; Jodi B Segal
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

8.  Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.

Authors:  Chris Cameron; Bruce Fireman; Brian Hutton; Tammy Clifford; Doug Coyle; George Wells; Colin R Dormuth; Robert Platt; Sengwee Toh
Journal:  Syst Rev       Date:  2015-11-05

9.  Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.

Authors:  Elizabeth E Roughead; Esther W Chan; Nam-Kyong Choi; Michio Kimura; Tomomi Kimura; Kiyoshi Kubota; Edward Chia-Cheng Lai; Kenneth K C Man; Tuan Anh Nguyen; Nobuhiro Ooba; Byung-Joo Park; Tsugumichi Sato; Ju-Young Shin; TongTong Wang; Jenna Griffiths; Ian C K Wong; Yea-Huei Kao Yang; Nicole L Pratt
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

10.  Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study.

Authors:  Tsugumichi Sato; Ching-Lan Cheng; Heung-Woo Park; Yea-Huei Kao Yang; Min-Suk Yang; Mizuki Fujita; Yuji Kumagai; Masahiro Tohkin; Yoshiro Saito; Kimie Sai
Journal:  Clin Transl Sci       Date:  2021-01-27       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.